Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp, trading under the ticker FLAC, is a blank-check company sponsored by Frazier Life Sciences, the life sciences-focused investment arm of Frazier Healthcare Partners. The company completed its initial public offering in 2020 and targets acquisition opportunities in the life sciences and biopharmaceutical sector, concentrating on businesses in therapeutics, medical devices, and related healthcare innovation. The 10-Q filed with the SEC on May 24, 2021, under accession number 0001193125-21-171117, reflects the company's status during its active search period for a qualifying business combination target. Visit SpacDesk and sign up for full access to FLAC's filings, timeline data, and sponsor intelligence.